Magnetic resonance brain tumor imaging in canine glioma
- 1 July 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 37 (7) , 1235
- https://doi.org/10.1212/wnl.37.7.1235
Abstract
This study investigates a canine model of experimental brain tumor. Particularly addressed was the usefulness of gadolinium contrast-enhanced MRI for differentiating brain tumor tissue from cerebral edema. Cultured canine glioma cells were injected into the left hemispheres of six adult mongrel dogs. All dogs developed brain tumors. Serum samples drawn prior to and serially after tumor inoculation showed development of antibodies reactive to the tumor. All tumors were visualized with MRI. Contrast-enhanced T1-weighted imaging was the most sensitive with gadolinium producing tumor enhancement due to blood-brain barrier breakdown. Gross and microscopic autopsy findings correlated well with MRIs.This publication has 8 references indexed in Scilit:
- Contrast Enhanced MRIInvestigative Radiology, 1985
- Intravascular contrast agents suitable for magnetic resonance imaging.Radiology, 1984
- Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complexAmerican Journal of Roentgenology, 1984
- Characteristics of gadolinium-DTPA complex: a potential NMR contrast agentAmerican Journal of Roentgenology, 1984
- Clinical NMR imaging of the brain: 140 casesAmerican Journal of Roentgenology, 1982
- Preliminary experimental results in humans and animals with a superconducting, whole-body, nuclear magnetic resonance scanner.Radiology, 1982
- Initial Clinical Evaluation of a Whole Body Nuclear Magnetic Resonance (NMR) TomographJournal of Computer Assisted Tomography, 1982
- Display of cross sectional anatomy by nuclear magnetic resonance imagingThe British Journal of Radiology, 1978